Correlation Between Tarsus Pharmaceuticals and Valens
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Valens at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Valens into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Valens, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Valens and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Valens. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Valens.
Diversification Opportunities for Tarsus Pharmaceuticals and Valens
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tarsus and Valens is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Valens in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valens and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Valens. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valens has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Valens go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Valens
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.58 times more return on investment than Valens. However, Tarsus Pharmaceuticals is 1.72 times less risky than Valens. It trades about 0.3 of its potential returns per unit of risk. Valens is currently generating about -0.03 per unit of risk. If you would invest 3,303 in Tarsus Pharmaceuticals on September 24, 2024 and sell it today you would earn a total of 2,151 from holding Tarsus Pharmaceuticals or generate 65.12% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Tarsus Pharmaceuticals vs. Valens
Performance |
Timeline |
Tarsus Pharmaceuticals |
Valens |
Tarsus Pharmaceuticals and Valens Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tarsus Pharmaceuticals and Valens
The main advantage of trading using opposite Tarsus Pharmaceuticals and Valens positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Valens can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valens will offset losses from the drop in Valens' long position.Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |